DnB Asset Management’s Ultragenyx Pharmaceutical RARE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $535K | Buy |
14,720
+452
| +3% | +$16.4K | ﹤0.01% | 646 |
|
|
2025
Q1 | $517K | Buy |
14,268
+2,136
| +18% | +$77.3K | ﹤0.01% | 654 |
|
|
2024
Q4 | $510K | Buy |
12,132
+1,889
| +18% | +$79.5K | ﹤0.01% | 661 |
|
|
2024
Q3 | $569K | Sell |
10,243
-2,699
| -21% | -$150K | ﹤0.01% | 655 |
|
|
2024
Q2 | $532K | Buy |
12,942
+2,921
| +29% | +$120K | ﹤0.01% | 649 |
|
|
2024
Q1 | $468K | Buy |
+10,021
| New | +$468K | ﹤0.01% | 655 |
|
|
2023
Q4 | – | Sell |
-12,674
| Closed | -$452K | – | 664 |
|
|
2023
Q3 | $452K | Buy |
12,674
+848
| +7% | +$30.2K | ﹤0.01% | 637 |
|
|
2023
Q2 | $546K | Buy |
+11,826
| New | +$546K | ﹤0.01% | 632 |
|